Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy | MicrobiomeTrials← Back to trialsNCT06495424
Observational Study to Evaluate the Efficacy of Sustained QUTENZA® Use in Painful Diabetic Peripheral Neuropathy
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-03-14Est. Completion: 2027-03-01
Enrollment target: 144 participants Locations- Center for Interventional Pain and Spine, Wilmington, Delaware, United States
- Horizon Clinical Research, Gainesville, Georgia, United States
- Horizon Clinical Research, Jasper, Georgia, United States
- Horizon Clinical Research, Newnan, Georgia, United States
- Iqra Research, Edgewood, Kentucky, United States
- Curalta Clinical Trials, Oradell, New Jersey, United States
- Iqra Research, Cincinnati, Ohio, United States
- Center for Interventional Pain and Spine, Bryn Mawr, Pennsylvania, United States
- Center for Interventional Pain and Spine, Fort Washington, Pennsylvania, United States
- Center for Interventional Pain and Spine, Lancaster, Pennsylvania, United States
Other microbiome trials you might be interested in
Painful Diabetic Peripheral Neuropathy (PDPN)
The study is a single-center, randomized, participant- and observer-masked, human-subjects, post-market clinical pilot s…
La Jolla, United StatesEst. completion Aug 2026
Diabetic Peripheral Neuropathy
This study is a single-center, randomized, single-blind, sham-controlled clinical trial aimed at evaluating the efficacy…
Chongqing, ChinaEst. completion May 20, 2027
Arteritis, Giant CellBlindness and Low Vision
Giant cell arteritis , also named Horton's disease, is the most common vasculitis in subjects over 50 years old. The inc…
Cannes, FranceCompleted Jul 26, 2023